Skip to content
healthcare.dev

Allergy relief-D

NDC 51660-940, Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride, tablet, film coated, extended release, from Ohm Laboratories Inc..

Product NDC
51660-940
Status
Listed
Labeler
Ohm Laboratories Inc.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA090922
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51660-940 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE5 mg/1
  • PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
51660-940-12516600940122 BLISTER PACK in 1 CARTON (51660-940-12) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
51660-940-24516600940244 BLISTER PACK in 1 CARTON (51660-940-24) / 6 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 51660094024

    GET /v1/drugs/nadac/51660094024

Use it

Look up 51660-940 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51660-940 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51660-940. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.